Tempest Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $11.6M | $106.3M | $25.4M |
| Jun 2017 | $12.7M | $93.9M | $22.9M |
| Sep 2017 | $9.7M | $82.0M | $24.8M |
| Dec 2017 | $4.8M | $19.8M | $17.6M |
| Mar 2018 | $5.7M | $63.0M | $19.7M |
| Jun 2018 | $5.3M | $55.5M | $24.6M |
| Sep 2018 | $4.3M | $49.2M | $31.9M |
| Dec 2018 | $11.0M | $84.1M | $73.3M |
| Mar 2019 | $10.6M | $74.3M | $65.6M |
| Jun 2019 | $13.3M | $68.3M | $55.3M |
| Sep 2019 | $13.7M | $58.5M | $47.2M |
| Dec 2019 | $15.1M | $75.0M | $62.5M |
| Mar 2020 | $13.4M | $68.0M | $58.0M |
| Jun 2020 | $12.2M | $57.1M | $50.3M |
| Sep 2020 | $4.9M | $22.9M | $18.8M |
| Dec 2020 | $4.9M | $22.9M | $18.8M |
| Mar 2021 | $37.1M | $73.2M | $51.8M |
| Jun 2021 | $27.4M | $75.5M | $68.4M |
| Sep 2021 | $23.6M | $67.1M | $59.7M |
| Dec 2021 | $37.1M | $73.2M | $51.8M |
| Mar 2022 | $37.6M | $67.0M | $45.8M |
| Jun 2022 | $36.4M | $71.4M | $51.6M |
| Sep 2022 | $36.4M | $63.2M | $42.8M |
| Dec 2022 | $28.0M | $46.1M | $31.2M |
| Mar 2023 | $26.4M | $37.3M | $22.9M |
| Jun 2023 | $25.7M | $30.7M | $17.6M |
| Sep 2023 | $25.2M | $24.0M | $11.1M |
| Dec 2023 | $24.8M | $51.6M | $39.2M |
| Mar 2024 | $23.7M | $44.4M | $32.3M |
| Jun 2024 | $25.2M | $42.2M | $31.1M |
| Sep 2024 | $22.4M | $33.8M | $22.1M |
| Dec 2024 | $22.4M | $41.5M | $30.3M |
| Mar 2025 | $21.0M | $32.2M | $21.5M |
| Jun 2025 | $14.7M | $24.5M | $14.3M |
| Sep 2025 | $10.8M | $17.1M | $7.5M |
| Dec 2025 | $10.3M | $16.9M | $7.7M |
| Mar 2026 | $9.9M | $10.7M | $1.8M |
| Jun 2026 | $10.7M | $9.6M | $779.0K |